India's pharmaceutical industry grows 24% every year and is anticipated to reach $85 billion by 2020. 33% of the world's medications are exported from India, and it is the main provider of generic medicine for a long time. The four primary items in this industry are branded generic medicine, branded drugs, unbranded generic medicine, and Active pharmaceutical ingredients (APIs).
India's pharmaceutical segment is described by high plan advancement ability and low expenses for production and research. The nation's large diverse populace makes it a prime area for clinical trials. Expanding urbanization, buyer spending, and purchase of health care insurance can add to the development of this division.
The future is really bright for India’s pharmaceutical industry as it keeps growing in recent time. As a result, the India population can experience positive health trends and expensive medicines become quite affordable.
Our healthcare vertical experts can assist global clients-covering the whole spectrum of research, acquisition, distributing network to get the unprecedented growth of the healthcare market in India.